Vanguard Group’s Matinas BioPharma MTNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $35K | Hold |
59,725
| – | – | ﹤0.01% | 4276 |
|
|
2025
Q3 | $113K | Hold |
59,725
| – | – | ﹤0.01% | 4212 |
|
|
2025
Q2 | $53.2K | Hold |
59,725
| – | – | ﹤0.01% | 4193 |
|
|
2025
Q1 | $31.1K | Sell |
59,725
-46,769
| -44% | -$27.7K | ﹤0.01% | 4223 |
|
|
2024
Q4 | $54.3K | Sell |
106,494
-79,863
| -43% | -$122K | ﹤0.01% | 4209 |
|
|
2024
Q3 | $660K | Hold |
186,357
| – | – | ﹤0.01% | 3901 |
|
|
2024
Q2 | $1.48M | Hold |
186,357
| – | – | ﹤0.01% | 3663 |
|
|
2024
Q1 | $2.53M | Hold |
186,357
| – | – | ﹤0.01% | 3517 |
|
|
2023
Q4 | $2.01M | Buy |
186,357
+11,281
| +6% | +$127K | ﹤0.01% | 3600 |
|
|
2023
Q3 | $1.14M | Buy |
175,076
+668
| +0.4% | +$8.2K | ﹤0.01% | 3787 |
|
|
2023
Q2 | $3.14M | Sell |
174,408
-795
| -0.5% | -$18.5K | ﹤0.01% | 3504 |
|
|
2023
Q1 | $4.12M | Buy |
175,203
+3,073
| +2% | +$77.6K | ﹤0.01% | 3394 |
|
|
2022
Q4 | $4.3M | Buy |
172,130
+3,527
| +2% | +$117K | ﹤0.01% | 3376 |
|
|
2022
Q3 | $5.36M | Buy |
168,603
+322
| +0.2% | +$12.6K | ﹤0.01% | 3291 |
|
|
2022
Q2 | $6.65M | Buy |
168,281
+10,583
| +7% | +$403K | ﹤0.01% | 3218 |
|
|
2022
Q1 | $6.34M | Sell |
157,698
-952
| -0.6% | -$35K | ﹤0.01% | 3405 |
|
|
2021
Q4 | $8.01M | Buy |
158,650
+1,028
| +0.7% | +$55K | ﹤0.01% | 3346 |
|
|
2021
Q3 | $10.2M | Buy |
157,622
+173
| +0.1% | +$7.46K | ﹤0.01% | 3227 |
|
|
2021
Q2 | $6.1M | Buy |
157,449
+412
| +0.3% | +$17.7K | ﹤0.01% | 3485 |
|
|
2021
Q1 | $8.24M | Buy |
157,037
+3,064
| +2% | +$206K | ﹤0.01% | 3255 |
|
|
2020
Q4 | $10.5M | Buy |
153,973
+1,550
| +1% | +$71.8K | ﹤0.01% | 2967 |
|
|
2020
Q3 | $5.84M | Hold |
152,423
| – | – | ﹤0.01% | 3076 |
|
|
2020
Q2 | $5.89M | Buy |
152,423
+932
| +0.6% | +$35.7K | ﹤0.01% | 3030 |
|
|
2020
Q1 | $4.54M | Buy |
151,491
+45,315
| +43% | +$2.74M | ﹤0.01% | 3006 |
|
|
2019
Q4 | $12.1M | Buy |
106,176
+2,538
| +2% | +$147K | ﹤0.01% | 2770 |
|
|
2019
Q3 | $3.27M | Buy |
103,638
+3,680
| +4% | +$133K | ﹤0.01% | 3281 |
|
|
2019
Q2 | $4.28M | Buy |
99,958
+28,382
| +40% | +$1.36M | ﹤0.01% | 3221 |
|
|
2019
Q1 | $3.9M | Buy |
71,576
+16,340
| +30% | +$880K | ﹤0.01% | 3222 |
|
|
2018
Q4 | $1.64M | Buy |
55,236
+4,569
| +9% | +$179K | ﹤0.01% | 3432 |
|
|
2018
Q3 | $2.33M | Sell |
50,667
-321
| -0.6% | -$6.9K | ﹤0.01% | 3475 |
|
|
2018
Q2 | $1.11M | Sell |
50,988
-4,695
| -8% | -$136K | ﹤0.01% | 3661 |
|
|
2018
Q1 | $2.13M | Buy |
55,683
+1,692
| +3% | +$89.5K | ﹤0.01% | 3439 |
|
|
2017
Q4 | $3.13M | Buy |
53,991
+1,278
| +2% | +$82.2K | ﹤0.01% | 3291 |
|
|
2017
Q3 | $3.48M | Buy |
52,713
+3,773
| +8% | +$252K | ﹤0.01% | 3241 |
|
|
2017
Q2 | $4.13M | Buy |
+48,940
| New | +$6.57M | ﹤0.01% | 3156 |
|
Other funds holding MTNB
DS
HIW
XT
VF